Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectrum Pharmaceuticals Inc.

www.sppirx.com/

Latest From Spectrum Pharmaceuticals Inc.

Hanmi Faces Another Licensee U-Turn, This Time Janssen On Obesity/Diabetes Drug

Janssen has returned the rights to an obesity/diabetes drug to originator Hanmi, after Phase II studies failed to achieve glycemic control targets and reflecting development difficulties in the sector. This is the fourth time for the Korean firm to face a U-turn of licensed out compounds. 

South Korea Deals

Aurobindo Upbeat On Outlook As It Moves To Close Sandoz Deal

India's Aurobindo says it is betting its $1bn purchase of Sandoz' US dermatology assets will help “really fuel growth” and that the company's biggest acquisition should be wrapped up in eight to 12 weeks.

Commercial Companies

Aurobindo Expects Sandoz Business To Over-Perform

Aurobindo is betting that its $1bn purchase of Sandoz’ US assets will beat its earlier expectations and help to fuel significant growth for the Indian firm. It expects the acquisition, the company’s biggest ever, to close within 8-12 weeks.

Deals Strategy

Deal Watch: Gilead Moves Into Kidney Disease Via Goldfinch Collaboration

Goldfinch’s Kidney Genome Atlas may yield novel therapies for diabetic kidney disease and orphan renal indications, with Gilead holding option rights. Spectrum licenses IP from ImmunGene that could safely harness the potential of interferon therapy in cancer.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Alias(es)
  • NeoTherapeutics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Spectrum Pharmaceuticals Inc.
  • Senior Management
  • Joseph W Turgeon, Pres. & CEO
    Kurt Gustafson, EVP, CFO & Principal Accounting Officer
    Thomas Riga, COO
    Bimal R Shah, VP, Corp. & Bus. Dev.
    Francois Lebel, MD, CMO
  • Contact Info
  • Spectrum Pharmaceuticals Inc.
    Phone: (702) 835-6300
    11500 South Eastern Ave.
    Ste. 240
    P.O. Box 5702 Henderson, NV 89052
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register